The Minnesota Cancer Clinical Trials Network (MNCCTN) aims to improve cancer outcomes for all Minnesotans through greater access to cancer clinical trials in prevention and treatment.
The impact of cancer in Minnesota
Nearly half of all Minnesotans will be diagnosed with a potentially life-threatening cancer during their lifetimes
One out of four Minnesotans die of cancer
To impact these grim statistics, healthcare providers across the state need access to cutting-edge cancer research, including cancer clinical trials.
Led by the Masonic Cancer Center, University of Minnesota, the network is funded in partnership with the State of Minnesota